Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate Tablet
Product Images NDC 67296-2191

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate (NDC 67296-2191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalstructurebupren (Chemicalstructure1)

Chemical structure of Buprenorphine Hydrochloride, a component of the combination drug BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE. The diagram shows the molecular structure including aromatic rings, hydroxyl groups, and a cyclopropylmethyl substituent, along with the indicated hydrochloride (HCl) salt form.*

FDA Label Image

Chemicalstructurenal (Chemicalstructure2)

Chemical structure of Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate, showing molecular bonds and elements with notation for hydrochloride and two water molecules (dihydrate).*

FDA Label Image

Containerlabel2mgpoint5mg (Containerlabel2mgpoint5mg)

The label is for Buprenorphine and Naloxone Sublingual Tablets with a strength of 2 mg/0.5 mg. It indicates a 30-tablet count and states the product is distributed by Accord Healthcare, Inc. and manufactured by WES Pharma Inc. Storage instructions specify 20° to 25°C. The label includes warnings about accidental ingestion by children and pharmacist dispensing instructions.*

FDA Label Image

Containerlabel8mg2mg (Containerlabel8mg2mg)

Label for Buprenorphine and Naloxone Sublingual Tablets, 8 mg/2 mg strength, containing 30 tablets. Distributed by Accord Healthcare, manufactured by WES Pharma Inc. The label includes storage instructions, dosage form, and pharmacist dispensing information. The NDC number 16729-550-10 is visible along with a barcode.*

FDA Label Image

Figure1 (Fig1)

An illustration depicting a person placing a sublingual tablet under their tongue using their fingers. The open mouth and visible tongue show the correct placement of the tablet for sublingual administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.